“I couldn’t design a vaccine if I wanted to, to be more likely to drive immune imprinting,” Malone, who helped invent the messenger RNA technology the Pfizer and Moderna vaccines are built on, told The Epoch Times.
Immune imprinting refers to a phenomenon whereby initial exposure to a virus strain may prevent the body from producing enough neutralizing antibodies against a new viral strain.
The COVID-19 vaccines currently in circulation are based on the Wuhan strain of the CCP (Chinese Communist Party) virus. Also known as SARS-CoV-2, the virus causes COVID-19.
A number of strains have emerged and become dominant since the Wuhan strain was prevalent, including the currently dominant Omicron variant.
Researchers with Imperial College London and the United Kingdom Health Security Agency found that people who received three doses of a COVID-19 vaccine and were infected with the Wuhan strain had a lower level of protection against later strains when compared to people who had not been infected. Other groups, including researchers with the Beth Israel Deaconess Medical Center, have found the vaccines much less effective against Omicron subvariants than the Wuhan strain.
A number of studies have found negative effectiveness among vaccinated groups. That means those who get vaccinated are more likely to get infected.
In some areas, the vaccinated account for a majority of those infected or in hospitals or dying with COVID-19. In Louisiana, for example, 70 percent of the deaths recorded between June 23 and June 29 were among the vaccinated.
Second Booster Push
The vaccines were originally promoted as two-shot primary regimens (Pfizer and Moderna) or a one-shot immunization (Johnson & Johnson). They were said to have efficacy as high as 100 percent against symptomatic infection.